This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Addgene
product type :
cDNA
product name :
pLV-neo-CD2-FAK
catalog :
37013
citations: 5
Reference |
---|
Pollan S, Teng P, Jan Y, Livingstone J, Huang C, Kim M, et al. Loss of CDCP1 triggers FAK activation in detached prostate cancer cells. Am J Clin Exp Urol. 2021;9:350-366 pubmed
|
product information
Catalog Number :
37013
Product Name :
pLV-neo-CD2-FAK
article :
doi | 10.1073/pnas.0904227106 |
id | 5349 |
pubmed_id | 19502425 |
bacterial resistance :
Ampicillin
cloning :
backbone | pLV-IRES-neo | ||
backbone_mutation | pLV-IRES-neo (a gift from I. Ben-Porath) was generated by replacing dsRed2 in pLV-tTRKRAB-Red (Addgene plasmid 12250) with the neomycin-resistance gene and removing the sequence of tTR-KRAB. | ||
backbone_origin | I. Ben-Porath | ||
backbone_size | |||
promoter | |||
sequencing_primer_3 | |||
sequencing_primer_5 | |||
vector_types |
|
origin :
37
pi :
|
plasmid copy :
CD2-FAK was acquired from Dr. Steven Frisch (Frisch SM et al, 1996, JCB 134, 793).
resistance markers :
568 |
tags :
Unknown
terms :
Neomycin (select with G418) |
company information
Addgene
490 Arsenal Way, Suite 100
Watertown, MA 02472
Watertown, MA 02472
info@addgene.org
https://www.addgene.org617.225.9000
headquarters: USA
questions and comments